Open access
Aug 2026
SLPI is associated with AR-regulated epithelial adaptation and enzalutamide sensitivity in castration-resistant prostate cancer
Findings place SLPI at the intersection of AR-pathway state, epithelial adaptation, immune-context changes, and enzalutamide sensitivity in CRPC, which may represent a therapy-response-associated epithelial factor in prostate cancer.
Zhen-Yao Zhu, Yuyong Shen, Xing-Ying He et al.
· Frontiers in Pharmacology · 0 citations